Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Cotransporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance, and Ketoconazole Interaction Studies-Reference-Cited by-同舟云学术

Assessment of the Drug Interaction Risk for Remogliflozin Etabonate, a Sodium-Dependent Glucose Cotransporter-2 Inhibitor: Evidence from In Vitro, Human Mass Balance, and Ketoconazole Interaction Studies

Published:2012-07-30 Issue:11 Volume:40 Page:2090-2101
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Sigafoos James F.,Bowers Gary D.,Castellino Stephen,Culp Amanda G.,Wagner David S.,Reese Melinda J.,Humphreys Joan E.,Hussey Elizabeth K.,O'Connor Semmes Robin L.,Kapur Anita,Tao Wenli,Dobbins Robert L.,Polli Joseph W.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference39 articles.

1. Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs;Asano;Curr Med Chem,2004

2. Renal sodium–glucose transport: role in diabetes mellitus and potential clinical implications

3. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9

4. From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus

5. BDDCS Applied to Over 900 Drugs

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remogliflozin Etabonate (Re) the Latest Addition to the SGLT2 Inhibitor;Asian Journal of Pharmacy and Technology;2024-03-04

2. Bioequivalence Study and Bioanalytical Method Development of Remogliflozin etabonate tablets in wistar rat plasma using RP-HPLC Method;Research Journal of Pharmacy and Technology;2024-02-20

3. Green high‐performance thin layer chromatography‐densitometric approach for tablet formulation containing remogliflozin etabonate and vildagliptin;SEPARATION SCIENCE PLUS;2023-07-23

4. Progress in Analytical Techniques for Remogliflozin Etabonate, Vildagliptin And Metformin Hydrochloride: A Recently, Approved FDC;Current Pharmaceutical Analysis;2023-02

5. Stability Indicating Method for the Assay of Remogliflozin Etabonate and its Related Substances by RP-HPLC;Analytical Chemistry Letters;2023-01-02